Bromelain, Comosain as a New Drug for Treating and Preventing Various Types of Cancer in the Humans
Clinical trial NCT02340845 · UNKNOWN
Trial details
- NCT number
- NCT02340845
- Sponsor
- Oeyama-Moto Cancer Research Foundation
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2015-01-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.